The most important carcinogenic mechanism and cellular dysfunctions at this stage of CRC are as follows: MIR133B is modified by DNA methylation to downregulate GDNF and SMC2, inhibiting tumor proliferation and migration. The gene discussed is MIR133B; the disease is neoplasm.